Cargando…
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
Pulmonary arterial hypertension (PAH) is a progressive and fatal disease without a cure. The exact pathogenic mechanisms of PAH are complex and poorly understood, yet a number of abnormally expressed genes and regulatory pathways contribute to sustained vasoconstriction and vascular remodeling of th...
Autores principales: | Babicheva, Aleksandra, Makino, Ayako, Yuan, Jason X.-J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926633/ https://www.ncbi.nlm.nih.gov/pubmed/33670032 http://dx.doi.org/10.3390/ijms22042144 |
Ejemplares similares
-
mTOR Signaling and Potential Therapeutic Targeting in Meningioma
por: Pinker, Benjamin, et al.
Publicado: (2022) -
The Role of mTOR Signaling as a Therapeutic Target in Cancer
por: Popova, Nadezhda V., et al.
Publicado: (2021) -
mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014) -
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019) -
mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)